𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis

✍ Scribed by Earl D. Silverman; Ronald M. Laxer; Mark Greenwald; Erwin Gelfand; Abraham Shore; Leonard D. Stein; Chaim M. Roifman


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
574 KB
Volume
33
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Immunomodulating effect of human placent
✍ J. Sany; J. Clot; M. Bonneau; M. Andary πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 686 KB

## Abstract Patients who had active and severe rheumatoid arthritis (RA) were treated with human placenta‐eluted gamma globulins (PEGG) composed of purified IgG eluted from trophoblastic cells. A control group of RA patients received retroplacental gamma globulins with no clinical effects. Seven of

Gold therapy in the management of juveni
✍ Earl J. Brewer Jr.; Dr. Edward H. Giannini; Elizabeth Barkley πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 642 KB

## Abstract Gold therapy for 6 months was shown to be efficacious in reducing the severity of articular manifestations in 32 (63%) of 51 juvenile rheumatoid arthritis patients reviewed retrospectively. Similarly, reductions in the total number of involved joints were seen in 25 (49%) patients. Pati

Methotrexate therapy in juvenile rheumat
✍ H. Truckenbrodt; R. HΓ€fner πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 614 KB

Nineteen selected patients with severe, mostly systemic onset, juvenile rheumatoid arthritis were treated with methotrexate (MTX) for an average of 10.5 months. Twelve patients showed statistically significant improvement, as measured by the number of affected, swollen, tender, and functionally impa